ArticleIranian journal of pathology2024

Targeted Therapy with a Novel Superantigen-based Fusion Protein Against Interleukin-13 Receptor α2-overexpressing Tumor Cells: An In-silico Study.

Zahra Gholipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.